Contineum Therapeutics (CTNM) Earnings Date & Reports

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CTNM is expected to report earnings to rise 12.50% to -44 cents per share on October 29

Contineum Therapeutics CTNM Stock Earnings Reports

Q3'26

Est.

$-0.45

Q2'26

Beat

by $0.04

Q1'26

Beat

by $0.46

Q4'25

Beat

by $0.16

Q3'25

Beat

by $0.15

The last earnings report on July 31 showed earnings per share of -40 cents, beating the estimate of -43 cents. With 269.23K shares outstanding, the current market capitalization sits at 315.83M.

View a ticker or compare two or three

Ask AI

Compare

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

Realized ReturnView

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

CTNM

Setup

Daily Signal:

Description

Gain/Loss: